Unstable Angina Pectoris in Comorbidity With Anxiety-depressive Syndrome
Coronary Heart DiseaseIntroduction: Today it is necessary to emphasize that coronary heart disease is often associated with anxiety disorders. Research over the years has shown several and sometimes surprising links between coronary heart disease and mental illness, and has even suggested that both of these phenomena may actually cause each other. However, the exact nature of these links has not yet been clearly established. Methods: The study included 202 patients with coronary artery disease, of whom 42 patients were with stable angina pectoris, they participated as a control group, and 160 patients with unstable angina pectoris, who made up the main group. Among them there are 102 women and 100 men between the ages of 30 and 88. The average age was 63.75 ± 11.37 years. All study participants had blood in the morning on fasting after 8-12 hours of fasting from the cubital vein. Determination of the level of cytokines TNF-α, IL-1β, IL-4 and IL-10 in blood serum by enzyme-linked immunosorbent assay (ELISA). All participants in the study had blood drawn in the morning on fasting after 8-12 hours of fasting from the cubital vein. The level of uric acid was determined on the CYAN Start apparatus using a unified method. When examining patients with unstable angina pectoris were used: hospital anxiety and depression scale [Kozlova S.N. 2013]. And also the Spielberger-Khanin scale [Psychiatry - Hoffman A.G. 2010], developed by Spielberger Ch.D. and adapted by Yu.L. Khanin. to assess cognitive functions [Psychiatry - Gofman A.G. 2010].
A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System
Coronary Artery DiseaseThis study is a prospective, multi-center single arm registry trial, planning to enroll 785 subjects. All subjects will receive clinical follow-up at 1 month, 6 month, 9 month and 1, 2, 3, 4, 5 year after index procedure. The primary endpoint will be target lesion failure (TLF) at 1 year after index procedure,which will be analyzed to evaluate the efficacy and safety of the device.
Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables...
Percutaneous Coronary InterventionCoronary Heart Disease1 moreThe goal of this study is to evaluate the safety and effectiveness of endovascular interventional surgery instrument control system (ALLVAS®robot)and supporting consumables for coronary artery interventional surgery. Participants will will complete coronary intervention surgery with the assistance of robot system(ALLVAS®robot), and evaluate the effect of the use effect of robots and clinical treatment after surgery
Hybrid Revascularization Versus Coronary Artery Bypass Grafting
Coronary Artery DiseasePatients with multivessel coronary disease have a compromised blood flow in the hearts own vessels, due to stenoses, and they are often treated with a coronary artery bypass grafting surgery. This is a big heart operation where the sternum (breast plate) is split and the heart is once again given a sufficient blood flow, by redirecting blood to the compromised areas through grafts. Another method for treating coronary disease is with percutaneous coronary intervention, or an endovascular approach that can re-establish blood flow to the hearts vessels by lessening the stenoses. However, bypass surgery is still the treatment of choice when there are multiple vessels in the heart with significant disease. In this trial we want to examine if a less invasive approach, called hybrid revascularization, where we combine the best of both treatments is better than the current standard. The combination is a minimally invasive bypass surgery, called MIDCAB which makes a bypass graft through a key-hole surgery for the anterior vessel on the heart, and catheter treatment of all other vessels with significant stenoses. We will compare the hybrid revascularization with the conventional treatment with a full bypass surgery through a sternotomy. Our hypothesis is that a less invasive revascularization strategy gives a better clinical outcome than the current standard with coronary artery bypass surgery through a split sternum. To test our hypothesis we will conduct a multicenter randomized clinical trial.
Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery...
Coronary StenosisCoronary Artery Stenosis1 moreThe objective of this study is to evaluate safety and effectiveness of the SINOMED CBC coronary dilatation catheter during PCI in subjects with stenotic coronary arteries.
Development of CIRC Technologies
Cardiovascular DiseasesHeart Failure8 moreCardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Moreover, the intrinsic advantage of MRI's lack of exposure to ionizing radiation is particularly beneficial. At the same time, blood work can be very useful in early detection of certain cardiomyopathy, such as amyloid. However, there is a lack of agreement of on which markers are the most sensitive. This multi-study will allow us the unique opportunity to form a more comprehensive understanding for various cardiovascular diseases. Our team has developed novel cardiac MRI techniques that leverages endogenous tissue properties to reveal a milieu of deep tissue phenotypes including myocardial inflammation, fibrosis, metabolism, and microstructural defects. Among these phenotypes, myocardial microstructure has proven to be most sensitive to early myocardial tissue damage and is predictive of myocardial regeneration. In this study, the investigators aim to further study the importance of cardiac microstructure revealed by MRI in patient and healthy population and compare this novel technology with conventional clinical biomarkers.
Diastolic Hyperemia-Free Ratio in Patients With CAD
Coronary StenosisCoronary Artery DiseaseThe investigators aimed to identify the value of concordance between the diastolic hyperemia-free ratio (DFR) and fractional flow reserve (FFR) during pre-interventional and post-interventional period using a 0.014" COMET II Pressure Guidewire
CAPTURER PMCF Study ( rEPIC04D )
Coronary Artery Disease (CAD)Ischemic Heart DiseaseMulticenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of CAPTURER to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with CAPTURER .
Navitian PMCF Study ( rEPIC04C )
Coronary Artery Disease (CAD)Ischemic Heart DiseaseMulticenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Navitian to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Navitian.
CHD Patient's Concern on Cardiac Rehabilitation
Coronary Heart DiseaseCardiac RehabilitationOur study focuses on the question about primary cardiac rehabilitation (CR) patients with coronary heart disease are concerned about demonstrating the association between the patients' view of CR and social associated factors. In our study, all participants are invited to choose at least 1 question in 15 questions or provide their questions regarding their doubt about the CR after filling in their personal information. The selectable questions can be categorized into five titles: the content or purpose of CR, the method of CR, the advantage of CR, the adverse effect of CR, and the expenditure of CR.